Teleflex Inc (Teleflex) is a medical device company. The company’s diverse portfolio includes solutions in vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine, and respiratory care. It offers the products to hospitals, healthcare providers, distributors, and original equipment manufacturers through brands Arrow, Deknatel, LMA, Pilling, QuikClot, Rusch, UroLift, and Weck, among others. Teleflex's product and service portfolio includes vascular access devices like central venous catheters and intraosseous access systems, interventional products for coronary and peripheral vascular disease, anesthesia products such as laryngoscopes and pain management devices, and surgical products including ligating clips and staplers, interventional urology solutions like the UroLift System, respiratory products for oxygen therapy, and a range of urology products for bladder management. Additionally, it also offers technical support and repair of products, clinical support services, partial shipments and special orders. The company's products are used in critical care and surgical applications, marketed and sold worldwide through direct sales and distributors. The company operates its business through seven product categories: Vascular Access; Interventional; Anaesthesia; Surgical; Interventional Urology; OEM; And Other.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Teleflex is engaged in both internal and external research and development initiatives to provide innovative, safe, and effective products that enhance clinical value by reducing infections, improving patient and clinician safety, enhancing patient outcomes, and enabling less invasive procedures. The company also acquires or licenses products and technologies that align with its strategic objectives to offer a comprehensive range of product and service options to customers. The medical device industry, characterized by extensive product research and development and rapid technological advances, necessitates substantial investments in product development to ensure future success. Teleflex Inc focuses on designing and manufacturing new products and enhancing existing ones, while also seeking 510(k) clearance or qualifying for 510(k)-exempt status to reduce research and development costs and risks. Its R&D units are responsible for supporting the company's strategic objectives by developing innovative products that enhance clinical value, reduce infections, improve safety, and enable less invasive procedures. These units also focus on acquiring or licensing products and technologies that align with the company's strategic goals. In FY2025, the company spent US$144.7 million on R&D, which as a percentage of revenue, stood at 7.2% and grew 32.8% YoY.